UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Chemotherapy‐induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death

International journal of cancer, 2013-08, Vol.133 (3), p.624-636

2013

Volltextzugriff (PDF)

WEE1 Inhibition Alleviates Resistance to Immune Attack of Tumor Cells Undergoing Epithelial-Mesenchymal Transition

Cancer research (Chicago, Ill.), 2014-05, Vol.74 (9), p.2510-2519

2014

Volltextzugriff (PDF)

Brachyury, a Driver of the Epithelial―Mesenchymal Transition, Is Overexpressed in Human Lung Tumors: An Opportunity for Novel Interventions against Lung Cancer

Clinical cancer research, 2012-07, Vol.18 (14), p.3868-3879

2012

Volltextzugriff (PDF)

A combination trial of vaccine plus ipilimumab in metastatic castration-resistant prostate cancer patients: immune correlates

Cancer Immunology, Immunotherapy, 2014-04, Vol.63 (4), p.407-418

2014

Volltextzugriff (PDF)

Combining a Recombinant Cancer Vaccine with Standard Definitive Radiotherapy in Patients with Localized Prostate Cancer

Clinical cancer research, 2005-05, Vol.11 (9), p.3353-3362

2005

Volltextzugriff (PDF)

Phase I Study of Sequential Vaccinations With Fowlpox-CEA(6D)-TRICOM Alone and Sequentially With Vaccinia-CEA(6D)-TRICOM, With and Without Granulocyte-Macrophage Colony-Stimulating Factor, in Patients With Carcinoembryonic Antigen–Expressing Carcinomas

Journal of clinical oncology, 2005-02, Vol.23 (4), p.720-731

2005

Volltextzugriff (PDF)

Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti-PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells

Cancer immunology research, 2015-10, Vol.3 (10), p.1148-1157

2015

Volltextzugriff (PDF)

Short-term EGFR blockade enhances immune-mediated cytotoxicity of EGFR mutant lung cancer cells: rationale for combination therapies

Cell death & disease, 2016-09, Vol.7 (9), p.e2380-e2380

2016

Volltextzugriff (PDF)

Safety and Immunologic Response of a Viral Vaccine to Prostate-Specific Antigen in Combination with Radiation Therapy when Metronomic-Dose Interleukin 2 Is Used as an Adjuvant

Clinical cancer research, 2008-08, Vol.14 (16), p.5284-5291

2008

Volltextzugriff (PDF)

A Viral Vaccine Encoding Prostate-Specific Antigen Induces Antigen Spreading to a Common Set of Self-Proteins in Prostate Cancer Patients

Clinical cancer research, 2010-08, Vol.16 (15), p.4046-4056

2010

Volltextzugriff (PDF)

Potentiation of natural killer cells to overcome cancer resistance to NK cell-based therapy and to enhance antibody-based immunotherapy

Frontiers in immunology, 2023, Vol.14, p.1275904-1275904

2023

Volltextzugriff (PDF)

Effect of Talactoferrin Alfa on the Immune System in Adults With Non‐Small Cell Lung Cancer

The oncologist (Dayton, Ohio), 2013-07, Vol.18 (7), p.821-822

2013

Volltextzugriff (PDF)

An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele

Oncotarget, 2016-12, Vol.7 (52), p.86359-86373

2016

Volltextzugriff (PDF)

Combination Chemotherapy and Radiation of Human Squamous Cell Carcinoma of the Head and Neck Augments CTL-Mediated Lysis

Clinical cancer research, 2006-03, Vol.12 (6), p.1897-1905

2006

Volltextzugriff (PDF)

Overexpression of the EMT Driver Brachyury in Breast Carcinomas: Association With Poor Prognosis

JNCI : Journal of the National Cancer Institute, 2014-05, Vol.106 (5), p.1

2014

Volltextzugriff (PDF)

A Human Cytotoxic T-Lymphocyte Epitope and Its Agonist Epitope from the Nonvariable Number of Tandem Repeat Sequence of MUC-1

Clinical cancer research, 2004-03, Vol.10 (6), p.2139-2149

2004

Volltextzugriff (PDF)

Induction of Higher-Avidity Human CTLs by Vector-Mediated Enhanced Costimulation of Antigen-Presenting Cells

Clinical cancer research, 2005-08, Vol.11 (15), p.5603-5615

2005

Volltextzugriff (PDF)

Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer

Cancer Immunology, Immunotherapy, 2010-05, Vol.59 (5), p.663-674

2010

Volltextzugriff (PDF)

Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes

Cancer research (Chicago, Ill.), 2004-11, Vol.64 (21), p.7985-7994

2004

Volltextzugriff (PDF)

A Pilot Study of MUC-1/CEA/TRICOM Poxviral-Based Vaccine in Patients with Metastatic Breast and Ovarian Cancer

Clinical cancer research, 2011-11, Vol.17 (22), p.7164-7173

2011

Volltextzugriff (PDF)

Comparative analysis of MVA-CD40L and MVA-TRICOM vectors for enhancing the immunogenicity of chronic lymphocytic leukemia (CLL) cells

Leukemia research, 2010-10, Vol.34 (10), p.1351-1357

2010

Volltextzugriff (PDF)

Identification and Characterization of a Human Agonist Cytotoxic T-Lymphocyte Epitope of Human Prostate-specific Antigen

Clinical cancer research, 2002-01, Vol.8 (1), p.41-53

2002

Volltextzugriff (PDF)

Pilot Study of Vaccination with Recombinant CEA-MUC-1-TRICOM Poxviral-Based Vaccines in Patients with Metastatic Carcinoma

Clinical cancer research, 2008-05, Vol.14 (10), p.3060-3069

2008

Volltextzugriff (PDF)

Therapeutic Cancer Vaccines

Advances in Cancer Research, 2014, Vol.121, p.67-124

2014

Volltextzugriff (PDF)

TRICOM vector based cancer vaccines

Current pharmaceutical design, 2006, Vol.12 (3), p.351-361

2006

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(76)

Publikationsform

Sprache

Englisch
(89)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(52)
Science & Technology
(52)
Humans
(50)
Oncology
(36)
Immunotherapy
(31)
Biological And Medical Sciences
(29)
Medical Sciences
(27)
Tumors
(20)
Antineoplastic Agents
(19)
Male
(19)
Immunology
(18)
Pharmacology. Drug Treatments
(18)
Cancer Vaccines - Therapeutic Use
(17)
Female
(17)
Cell Line, Tumor
(15)
Carcinoembryonic Antigen - Immunology
(14)
Aged
(13)
Animals
(13)
Cancer Vaccines - Immunology
(13)
Middle Aged
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Chemotherapy‐induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death

WEE1 Inhibition Alleviates Resistance to Immune Attack of Tumor Cells Undergoing Epithelial-Mesenchymal Transition

Brachyury, a Driver of the Epithelial―Mesenchymal Transition, Is Overexpressed in Human Lung Tumors: An Opportunity for Novel Interventions against Lung Cancer

A combination trial of vaccine plus ipilimumab in metastatic castration-resistant prostate cancer patients: immune correlates

Combining a Recombinant Cancer Vaccine with Standard Definitive Radiotherapy in Patients with Localized Prostate Cancer

Phase I Study of Sequential Vaccinations With Fowlpox-CEA(6D)-TRICOM Alone and Sequentially With Vaccinia-CEA(6D)-TRICOM, With and Without Granulocyte-Macrophage Colony-Stimulating Factor, in Patients With Carcinoembryonic Antigen–Expressing Carcinomas

Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti-PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells

Short-term EGFR blockade enhances immune-mediated cytotoxicity of EGFR mutant lung cancer cells: rationale for combination therapies

Safety and Immunologic Response of a Viral Vaccine to Prostate-Specific Antigen in Combination with Radiation Therapy when Metronomic-Dose Interleukin 2 Is Used as an Adjuvant

A Viral Vaccine Encoding Prostate-Specific Antigen Induces Antigen Spreading to a Common Set of Self-Proteins in Prostate Cancer Patients

Potentiation of natural killer cells to overcome cancer resistance to NK cell-based therapy and to enhance antibody-based immunotherapy

Effect of Talactoferrin Alfa on the Immune System in Adults With Non‐Small Cell Lung Cancer

An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele

Combination Chemotherapy and Radiation of Human Squamous Cell Carcinoma of the Head and Neck Augments CTL-Mediated Lysis

Overexpression of the EMT Driver Brachyury in Breast Carcinomas: Association With Poor Prognosis

A Human Cytotoxic T-Lymphocyte Epitope and Its Agonist Epitope from the Nonvariable Number of Tandem Repeat Sequence of MUC-1

Induction of Higher-Avidity Human CTLs by Vector-Mediated Enhanced Costimulation of Antigen-Presenting Cells

Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer

Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes

A Pilot Study of MUC-1/CEA/TRICOM Poxviral-Based Vaccine in Patients with Metastatic Breast and Ovarian Cancer

Comparative analysis of MVA-CD40L and MVA-TRICOM vectors for enhancing the immunogenicity of chronic lymphocytic leukemia (CLL) cells

Identification and Characterization of a Human Agonist Cytotoxic T-Lymphocyte Epitope of Human Prostate-specific Antigen

Pilot Study of Vaccination with Recombinant CEA-MUC-1-TRICOM Poxviral-Based Vaccines in Patients with Metastatic Carcinoma

Therapeutic Cancer Vaccines

TRICOM vector based cancer vaccines

Suchergebnisse filtern